DREAMM-7

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

January, 2025

DREAMM-7

Jul 28, 2024, 12:28 | Insight

Ross Firestone: Antigen escape with BCMA-targeting therapies in multiple myeloma

Ross Firestone, Hematology/Oncology Fellow at Memorial Sloan Kettering Cancer Center, shared a post on X…

Jul 14, 2024, 02:56 | Drugs

Belamaf-based triplet regimens are effective in patients with R/R multiple myeloma - ASCO

ASCO shared on X: "The DREAMM-7 and DREAMM-8 studies established the effectiveness of belamaf-based triplet…

Jun 7, 2024, 14:45 | Blog

Manni Mohyuddin on DREAMM-7

Manni Mohyuddin shared on X/Twitter: "In DREAMM-7 (bela/bort/dex vs dara/bort/dex). Only 34% of pts len refractory.…

Jun 2, 2024, 15:31 | Insight

Myeloma Paper of the Day, June 2nd, suggested by Robert Orlowski

Robert Orlowski shared on X: "Myeloma Paper of the Day: DREAMM-7 study shows belantamab/bortezomib/dexamethasone superior…

Jan 14, 2024, 17:54 | Insight

Toni Choueiri: The February ASCO Plenary Series are here

Toni Choueiri posted on X/Twitter: "The February ASCO Plenary Series are here: Why??? Well...'Because Science can't…

All: 5 Posts: 1 - 100

'

FDA approved sotorasib with panitumumab for KRAS G12C-mutated colorectal cancer

'

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

'

Monica Bertagnolli is ending her tenure as NIH director

'

Karen Knudsen: Clinical trials are the most advanced form of cancer care

'

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023